Abstract
Chimeric-antigen receptor T (CAR-T) cell therapy has been researched in the clinical. However, CAR-T cell therapy for solid tumor is faced with lots of challenges such as cytokine storm, how to find the specific antigen and limitation of microenvironment of tumor. In this review, we will discuss the research of CAR-T cell therapy for solid tumors of digestive system, and possible solutions and future direction.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: IOP Conference Series: Materials Science and Engineering
Paper Title
Journal
Date
